RHYTHM PHARMACEUTICALS, INC.

By person

38 insiders · 351 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Foley Todd

Director

$1.70M (1)

$50.56M (47)

−$48.86M

909,258

1.32%

$95.64M

+122.9%

Smith Hunter C

Chief Financial Officer

—

$19.38M (51) scheduled

−$19.38M

114,024

0.1656%

$11.99M

—

Lee Jennifer Kayden

EVP, Head of North America

—

$16.91M (36) scheduled

−$16.91M

0.0000%

$0.00

−100.0%

Shulman Joseph

Chief Technical Officer

—

$15.73M (41) scheduled

−$15.73M

15,915

0.0231%

$1.67M

—

BAKER BROS. ADVISORS LP entity

Former 10% owner

$15.05M (2)

—

+$15.05M

1,878,242

2.73%

$197.57M

—

RA CAPITAL MANAGEMENT, L.P. entity

Former 10% Owner

—

$13.40M (12)

−$13.40M

4,360,860

6.33%

$458.72M

−10.7%

Mazabraud Yann

EVP, Head of International

—

$12.84M (17) scheduled

−$12.84M

55,655

0.0808%

$5.85M

+168.4%

Cramer Pamela J.

Chief Human Resources Officer

—

$10.96M (32) scheduled

−$10.96M

29,376

0.0427%

$3.09M

+1,080%

Meeker David P

President and CEO

$626.71K (2)

$10.77M (11) scheduled

−$10.15M

239,258

0.3475%

$25.17M

+752.3%

BARRETT M JAMES

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

BARRIS PETER J

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

BASKETT FOREST

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

KERINS PATRICK J

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

MOTT DAVID M

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

NEW ENTERPRISE ASSOCIATES 13 LP entity

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

SANDELL SCOTT D

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Viswanathan Ravi

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Flynn James E

10% owner

$6.04M (2)

—

+$6.04M

468,505

0.6805%

$49.28M

—

TETRAULT LYNN A.

Director

—

$5.40M (8) scheduled

−$5.40M

11,712

0.0170%

$1.23M

—

GOOD JENNIFER L

Director

—

$4.27M (3) scheduled

−$4.27M

11,712

0.0170%

$1.23M

—

MCGIRR DAVID W J

Director

—

$4.27M (2) scheduled

−$4.27M

11,712

0.0170%

$1.23M

—

Van der Ploeg Leonardus H.T.

Chief Scientific Officer

—

$2.73M (11) scheduled

−$2.73M

42,339

0.0615%

$4.45M

−34.2%

Gottesdiener Keith Michael

CEO & President

—

$2.48M (15)

−$2.48M

558,250

0.8108%

$58.72M

−0.3%

MPM BIOVENTURES V, L.P.

10% owner

$1.70M (1)

—

+$1.70M

2,696,392

3.92%

$283.63M

+9,078%

German Christopher Paul

Corporate Controller & CAO

—

$1.59M (9) scheduled

−$1.59M

0.0000%

$0.00

−100.0%

Desikan Nithya

Chief Commercial Officer

—

$1.55M (2) scheduled

−$1.55M

43,602

0.0633%

$4.59M

—

ORBIMED ADVISORS LLC entity

10% owner

$6.04M (1)

$4.66M (4)

+$1.37M

2,750,079

3.99%

$289.28M

—

Garfield Alastair

Chief Scientific Officer

—

$998.19K (6) scheduled

−$998.19K

2,295

0.0033%

$241.41K

—

PFIZER INC entity

10% owner

$680.00K (1)

—

+$680.00K

1,427,639

2.07%

$150.17M

—

Ipsen, S.A.

10% owner

$340.00K (1)

—

+$340.00K

833,099

1.21%

$87.63M

+39.0%

Roberts William T.

Chief Accounting Officer

—

$53.87K (3) scheduled

−$53.87K

7,872

0.0114%

$828.06K

+128.0%

THIRD ROCK VENTURES LP entity

10% owner

—

2,981,437

4.33%

$313.62M

+16,814%

Hadley Harbor Master Investors (Cayman) L.P.

10% owner

—

545,256

0.7919%

$57.36M

—

Mathers Edward T

Director

—

21,168

0.0307%

$2.23M

—

Arbuckle Stuart A

Director

—

11,712

0.0170%

$1.23M

—

JEAN CHRISTOPHE

Director

—

11,712

0.0170%

$1.23M

—

Bedrosian Camille L

Director

—

7,000

0.0102%

$736.33K

—

Exter Neil

Director

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Smith Hunter C

18 May 2026

Chief Financial Officer

Exercised, kept

3,000

$17.87

$53.61K

Smith Hunter C

2 Mar 2026

Chief Financial Officer

Exercised, kept

6,099

$6.80

$41.47K

Smith Hunter C

7 Jul 2025

Chief Financial Officer

Exercised, kept

6,986

$6.88

$48.06K

Lee Jennifer Kayden

9 Feb 2025

EVP, Head of North America

Exercised, kept

4,189

$6.80

$28.49K

Smith Hunter C

29 Dec 2023

Chief Financial Officer

Exercised, kept

10,500

$6.88

$72.24K

Smith Hunter C

16 Jun 2023

Chief Financial Officer

Exercised, kept

2,000

$6.88

$13.76K

Smith Hunter C

21 Apr 2021

Chief Financial Officer

Exercised, kept

5,000

$6.88

$34.40K

Smith Hunter C

19 Jan 2021

Chief Financial Officer

Exercised, kept

4,000

$6.88

$27.52K

Desikan Nithya

11 Aug 2020

Chief Commercial Officer

Exercised, kept

14,534

$6.88

$99.99K

Showing 250 of 351 transactions. The figures above use every one of them.

RHYTHM PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out